(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PSORIASIS SPEAKS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PSORIASIS SPEAKS

ST13

US500000087607896

Class

44

Filing

87607896

Registration

5463453

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

07/16/2026

Trademark type

Word

Nice classes

44

Filing date

09/14/2017

Registration date

05/08/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/08/2024

Last transaction

07/16/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

11/04/2010

First use in commerce

01/17/2011

Drawing code

4

Owner type

03

Owner location

Hamilton, BM

Examiner

ELLIOTT, LASHAWNDA E

Current location

Historical data usage

Holders and representatives

Holders

AbbVie Biotechnology Ltd

Representatives

Sonali Srivastava ABBVIE INC.

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Providing medical information to patients and healthcare professionalsinformation regarding medical conditions and treatments; Medical consultationproviding advice to healthcare professionals regarding medical conditions and treatment

Publications

History of USPTO decisions and trademark events.

22 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/16/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/16/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/16/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/16/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/08/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/08/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/08/2024

E815

TEAS SECTION 8 & 15 RECEIVED

01/23/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/08/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/08/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/20/2018

PUBO

PUBLISHED FOR OPPOSITION

02/20/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/31/2018

ALIE

ASSIGNED TO LIE

01/12/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/02/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

12/20/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/20/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

12/20/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/20/2017

DOCK

ASSIGNED TO EXAMINER

12/19/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/19/2017

NWAP

NEW APPLICATION ENTERED

09/18/2017

Continuous trademark protection

Get notified about every new filing that threatens PSORIASIS SPEAKS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.